• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2200122 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2022-09-24 view
JXSB2200121 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2022-09-24 view
JXSB2200112 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2022-09-07 view
JXSB2200111 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2022-09-07 view
JXSB2200019 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2022-02-14 view
JXSB2200018 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2022-02-14 view
JXSB2101052 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2021-08-25 F Hoffmann-La Roche Ltd(Switzerland) view
JXSB2101054 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2021-08-25 F Hoffmann-La Roche Ltd(Switzerland) view
JXSB2101053 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2021-08-25 F Hoffmann-La Roche Ltd(Switzerland) view
JXSB2000043 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2020-12-14 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-12-03 view
JXSB2000042 Gantenerumab注射液 gantenerumab Injection Biological Products(1) Supplementary Application 2020-12-03 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-12-03 view
JYSB2000338 Gantenerumab注射液 gantenerumab Injection Biological Products Supplementary Application 2020-07-08 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-07-07 view
JXSL2000119 Gantenerumab注射液 gantenerumab Injection Biological Products Import Drug Application 2020-07-08 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-07-07 view
JXSL2000085 Gantenerumab注射液 gantenerumab Injection Biological Products Import Drug Application 2020-07-03 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-07-02 view
JYSB2000276 Gantenerumab注射液 gantenerumab Injection Biological Products Supplementary Application 2020-06-30 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-06-29 view
JYSB2000195 Gantenerumab注射液 gantenerumab Injection Biological Products Supplementary Application 2020-05-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-26 view
JXSL1700083 Gantenerumab注射液 gantenerumab Injection Biological Products Import Drug Application 2017-12-04 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2018-08-27 view
JXSL1400016 Gantenerumab 注射液 gantenerumab Injection Biological Products Import Drug Application 2014-04-04 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2015-12-24 view
JXSL1400014 Gantenerumab 注射液 gantenerumab Injection Biological Products Import Drug Application 2014-04-04 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2015-12-24 view
JXSL1400017 Gantenerumab 注射液 gantenerumab Injection Biological Products Import Drug Application 2014-03-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2015-12-24 view